FORMULATION AND EVALUATION OF COLON TARGETED PELLETS OF BUMADIZONE CALCIUM

Shah Akashkumar Nareshkumar, Anil G. Raval
{"title":"FORMULATION AND EVALUATION OF COLON TARGETED PELLETS OF BUMADIZONE CALCIUM","authors":"Shah Akashkumar Nareshkumar, Anil G. Raval","doi":"10.32553/IJPBA.V7I3.125","DOIUrl":null,"url":null,"abstract":"Aim: The aim of this study was to Formulation and Evaluation of colon targeted pellets of Bumadizone Calcium \nObjective: Bumadizone Calcium is an acetic acid derivative, having irritation in stomach. Bumadizone Calcium has short half-life (4hrs) and undergoes first pass metabolism. It is pH-dependent. This research work was carried out to improve the bioavailability, patient compliance on oral colon targeted drug delivery. Bumadizone Calcium sustained release enteric coated pellets were prepared, which minimize the release of drug in stomach for treatment of IBD formulated by Extrusion Spheronization process. \nExperimental work done: Enteric coated pellets prepared by Extrusion Spheronization technique. Eudragit S100, HPMC, PVP K30, and Ethyl Cellulose were used as rate controlling polymers. In this study, a pH dependent colon targeted enteric coated pellets was established using 32 full factorial design by giving enteric coating with Eudragit S100. Different Concentration of Eudragit S100 as an enteric coating material (4%, 5%, & %6) and PVP K30 as a Binder (0.5%, 1% & 1.5%) are taken for the measurements of % Drug Release that are performed by using USP dissolution 1 (Basket type) at 50 rpm. The test is performed with gastric fluid (pH 1.2) at 37±0.5 for first 2 hours & then in phosphate buffer 6.8 for 4 hrs & finally in phosphate buffer pH 7.4 for 6 hrs. The prepared formulations were evaluated for drug-excipient compatibility study, flow property, drug content, and coating process efficiency. \nResults and Discussion: Optimized batch shown that less than 0.50% of the drug released at the end of 2 hrs in pH 1.2, less than 20% of drug released after end of 4 hrs in pH 6.8 and more than 85% at the end of 12 hrs in pH 7.4. \nConclusion: Bumadizone Calcium Enteric Coated pellets can be successfully formulated by addition of PVP K-30 as a binder and Eudragit S100 as Coating polymer. It was also concluded that prepared formulation minimizes drug release in stomach and avoid side effect of the drug. \nKeywords: Bumadizone calcium, Eudragit S100, Enteric coating, extrusion spheronization technique, 32 full factorial designs.","PeriodicalId":14229,"journal":{"name":"International Journal of Pharmaceutical and Biological Science Archive","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical and Biological Science Archive","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32553/IJPBA.V7I3.125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Aim: The aim of this study was to Formulation and Evaluation of colon targeted pellets of Bumadizone Calcium Objective: Bumadizone Calcium is an acetic acid derivative, having irritation in stomach. Bumadizone Calcium has short half-life (4hrs) and undergoes first pass metabolism. It is pH-dependent. This research work was carried out to improve the bioavailability, patient compliance on oral colon targeted drug delivery. Bumadizone Calcium sustained release enteric coated pellets were prepared, which minimize the release of drug in stomach for treatment of IBD formulated by Extrusion Spheronization process. Experimental work done: Enteric coated pellets prepared by Extrusion Spheronization technique. Eudragit S100, HPMC, PVP K30, and Ethyl Cellulose were used as rate controlling polymers. In this study, a pH dependent colon targeted enteric coated pellets was established using 32 full factorial design by giving enteric coating with Eudragit S100. Different Concentration of Eudragit S100 as an enteric coating material (4%, 5%, & %6) and PVP K30 as a Binder (0.5%, 1% & 1.5%) are taken for the measurements of % Drug Release that are performed by using USP dissolution 1 (Basket type) at 50 rpm. The test is performed with gastric fluid (pH 1.2) at 37±0.5 for first 2 hours & then in phosphate buffer 6.8 for 4 hrs & finally in phosphate buffer pH 7.4 for 6 hrs. The prepared formulations were evaluated for drug-excipient compatibility study, flow property, drug content, and coating process efficiency. Results and Discussion: Optimized batch shown that less than 0.50% of the drug released at the end of 2 hrs in pH 1.2, less than 20% of drug released after end of 4 hrs in pH 6.8 and more than 85% at the end of 12 hrs in pH 7.4. Conclusion: Bumadizone Calcium Enteric Coated pellets can be successfully formulated by addition of PVP K-30 as a binder and Eudragit S100 as Coating polymer. It was also concluded that prepared formulation minimizes drug release in stomach and avoid side effect of the drug. Keywords: Bumadizone calcium, Eudragit S100, Enteric coating, extrusion spheronization technique, 32 full factorial designs.
人类地酮钙结肠靶向微丸的研制与评价
目的:研究布马地酮钙结肠靶向微丸的研制与评价目的:布马地酮钙为醋酸衍生物,对胃有刺激性。Bumadizone钙具有较短的半衰期(4小时),并经历第一次代谢。它与ph值有关。本研究旨在提高口服结肠靶向给药的生物利用度和患者依从性。采用挤压滚圆工艺制备了布马地酮钙缓释肠溶微丸,使治疗IBD的药物在胃内释放最小化。实验工作:采用挤压滚圆技术制备肠溶微丸。以乌桕S100、HPMC、PVP K30和乙基纤维素为控速聚合物。在本研究中,采用32全因子设计,在肠内涂覆Eudragit S100,建立了pH依赖性结肠靶向肠溶微球。采用不同浓度的Eudragit S100作为肠溶包衣材料(4%、5%和%6)和PVP K30作为粘结剂(0.5%、1%和1.5%),采用USP溶出度1 (Basket型)在50 rpm下进行了%药物释放的测量。试验在37±0.5的胃液(pH 1.2)中进行,前2小时,然后在磷酸盐缓冲液6.8中进行4小时,最后在磷酸盐缓冲液pH 7.4中进行6小时。对所制备的制剂进行了药物-赋形剂相容性研究、流动特性、药物含量和包衣工艺效率的评价。结果与讨论:优化批料在pH 1.2条件下,2小时释放率小于0.50%;在pH 6.8条件下,4小时释放率小于20%;在pH 7.4条件下,12小时释放率大于85%。结论:以PVP K-30为粘结剂,以苦苣苔S100为包被聚合物,可成功制备布马地酮钙肠溶微丸。制备的制剂能最大限度地减少药物在胃中的释放,避免药物的副作用。关键词:布玛地酮钙,乌龙茶S100,肠溶包衣,挤出球化技术,32全因子设计
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信